Bill Snyder

(iStock image)
April 17, 2024

Common AFib drug linked to higher bleeding risk 

In a national retrospective study led by researchers at Vanderbilt University School of Medicine, diltiazem, when given in combination with the anticoagulant drugs apixaban (Eliquis) or rivaroxaban (Xarelto), significantly increased the risk of serious bleeding compared to metoprolol.

By Bill Snyder
(iStock image)
April 9, 2024

Heart disease, depression linked by inflammation: study

Coronary artery disease and major depression may be genetically linked via inflammatory pathways to an increased risk for cardiomyopathy, a degenerative heart muscle disease, researchers at Vanderbilt University Medical Center and Massachusetts General Hospital have found.

By Bill Snyder
(iStock image)
April 3, 2024

Excess salt linked to heart disease deaths in low-income group: study

Excessive consumption of dietary sodium likely was responsible for up to 30% of cardiovascular disease-related deaths among mostly low-income participants in a large cohort study conducted by Vanderbilt University Medical Center.

By Bill Snyder
From left, Jennifer Pietenpol, PhD, Eric Farber-Eger, Lauren LeStourgeon, MPH, Luisella Spiga, PhD, and John Kuriyan, PhD.
April 2, 2024

VUMC research staff honored for excellence in the lab, clinic

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 29 for research excellence during the 20th annual Research Staff Awards Ceremony.

By Bill Snyder
(iStock image)
April 1, 2024

Cell-specific variations in gene regulation may be key to treating pulmonary fibrosis

An international research team co-led by Vanderbilt University Medical Center has revealed how variations in gene regulation in different cell types drive pulmonary fibrosis, a progressive respiratory disorder characterized by scarring and loss of functional lung tissue.

By Bill Snyder
Kathleen Neuzil, MD, MPH
April 1, 2024

Distinguished Vanderbilt alum to lead the NIH Fogarty International Center

Kathleen Neuzil, MD, MPH, a former faculty member and distinguished alumna of the Vanderbilt MPH Program, has been appointed director of the Fogarty International Center and associate director for international research at the National Institutes of Health.

By Bill Snyder
March 29, 2024

VUMC’s John Koethe named director of the Tennessee Center for AIDS Research

John Koethe, MD, MSCI, associate professor of Medicine in the Division of Infectious Diseases at Vanderbilt University Medical Center, has been appointed director and principal investigator of the Tennessee Center for AIDS Research.
By Bill Snyder
March 28, 2024

VUMC team discovers antibodies that may prevent severe respiratory illness

Using a technique developed at Vanderbilt University Medical Center, researchers identified antibodies that are excellent leads as potential therapies for human parainfluenza virus 3, a leading cause of acute and potentially fatal respiratory illness.
By Bill Snyder
March 26, 2024

Vanderbilt Prize winner’s lecture focused on the joy of discovery

During her Discovery Lecture on March 21, Professor Dame Frances Ashcroft, recipient of the 2023 Vanderbilt Prize in Biomedical Science, spoke on the joy science has given her.
By Bill Snyder
March 25, 2024

VUMC team finds potential treatment for kidney fibrosis

By Bill Snyder
March 18, 2024

VUMC’s Jay Jerome honored by Microscopy Society of America

Jerome is the 2024 recipient of the Distinguished Scientist Award, which honors “preeminent senior scientists for a long-standing record of achievement in the field of microscopy and microanalysis.”
By Bill Snyder
March 18, 2024

VUMC’s Sunil Kripalani joins AHRQ Advisory Council

The Agency for Healthcare Research and Quality Council helps guide national priorities for health services research that promotes improvements in the quality, safety and efficiency of clinical practice.
By Bill Snyder